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ABSTRACT  
 
What kinds of evidence reliably support predictions of effectiveness for health and 
social care interventions? There is increasing reliance, not only for healthcare policy 
and practice but for more general social and economic policy deliberation, on 
evidence that comes from studies whose basic logic is that of JS Mill’s method of 
difference. These include randomized controlled trials (RCTs), case control studies, 
cohort studies, and some uses of causal Bayes nets and counterfactual-licensing 
models like ones commonly developed in econometrics. The topic of this paper is the 
‘external validity’ of causal conclusions from these kinds of studies. We shall argue 
two claims. Claim, negative: external validity is the wrong idea; claim, positive: 
‘capacities’ are almost always the right idea, if there is a right idea to be had. If we are 
right about these claims, it makes big problems for policy decisions. Many advice 
guides for grading policy predictions give top grades to a proposed policy if it has two 
good Mill’s-method-of difference studies that support it. But if capacities are to serve 
as the conduit for support from a method-of-difference study to an effectiveness 
prediction, much more evidence, and much different in kind, is required. We will 
illustrate the complexities involved with the case of Multisystemic Therapy (MST), an 
internationally adopted intervention to try to diminish antisocial behaviour in young 
people.  
The Limitations of RCTs in Predicting Effectiveness 
 
1. Introduction 
 
What kinds of evidence reliably support predictions of effectiveness for health and 
social-care interventions? There is increasing reliance on evidence that comes from 
studies whose basic logic is that of JS Mill’s method of difference. These include 
randomized controlled trials (RCTs), case control studies, cohort studies, and some 
uses of causal Bayes nets and counterfactual-licensing models like ones commonly 
developed in econometrics.  [1], [2] and references therein discuss these methods 
further. The topic of this paper is the venerable issue of the ‘external validity’ of 
causal conclusions from these kinds of studies. We shall argue two claims. Claim, 
negative: external validity is the wrong idea; claim, positive: ‘capacities’ are almost 
always the right idea, if any idea is right.  
 
If correct, these claims imply big problems for policy decisions. Often in making 
these decisions one hopes to rely on some solid Mill’s-method-of-difference studies. 
Indeed many advice guides for grading policy predictions give top grades to a 
proposed policy if two good Mill’s-method-of difference studies support it. But if 
capacities are to support an effectiveness prediction from a method-of-difference 
study, much more evidence, and much different in kind, is required, and at two stages: 
First, to support the capacity claim; second to supplement this claim to ensure the 
capacity will operate in the target situation, and operate in the expected way. So a lot 
more work is required than hoped. To illustrate the complexities involved we consider 
Multisystemic Therapy (MST), an intervention internationally adopted to diminish 
antisocial behaviour in young people. 
 
Section 2 below explains Mill’s method of difference, what it can establish, and why; 
section 3, some sufficient conditions for claims established by method-of-difference 
studies to be externally valid; section 4 introduces three  kinds of causal claims; 
section 5 explains capacities and their logic; section 6 explains why reasoning with 
capacities requires different evidence than method-of-difference studies provide; and 
section 7 describes the discrepant findings of RCTs on Multisystemic Therapy and the 
current difficulties in deciding how to interpret these results. 
 
2. Mill’s Method-of-Difference Studies 
 
Mill’s method-of-difference studies locate differences in the probability of a selected 
outcome (O) with and without the treatment/intervention (T) across two groups that 
have identical distributions for all factors causally relevant to the outcome except 
those causally downstream from the treatment. The intent is to draw a causal 
conclusion. But for that, some assumptions must be made to connect causes with 
probabilities. The most standard one, which we shall suppose here,1,is   
 
                                                 
1 There are other ways to draw this connection. Probably the other most dominant is that of Holland 
and Rubin [3]. This links method-of-difference studies to effectiveness predictions via singular 
counterfactuals. These two methods are closely connected however, which is apparent form the three 
decades old literature connecting probabilistic causality with the probability of counterfactual 
conditionals. 
Causal Fixing (CF): The probability of an effect is fixed by the values taken 
by a full set of its causes. 
 
RCTs, case control studies, cohort studies, and some uses of causal Bayes nets and 
counterfactual-licensing models like ones commonly developed in econometrics all 
follow the method-of-difference logic. This logic is deductive. That is its special 
strength. Given CF, if a positive probabilistic difference obtains and if the two groups 
have identical distributions of other causal factors, it follows T causes O in some 
subpopulation, φ, of the population (X) of the individuals in the study that is causally 
homogeneous with respect to O.2 The methods differ by how they try to match the 
distribution of other causes in the two groups and sometimes by the techniques used 
to infer probabilities from observed frequencies.  
 
 
3. External Validity 
 
We must be careful though. A positive difference between treatment and nontreatment 
groups shows that T causes O in some causally homogeneous subpopulation φ of X. 
This is a very narrow conclusion, of little use as it stands. Hence enters the venerable 
problem of external validity: When will the conclusion established for study 
population X hold for target population θ? 
 
                                                 
2 Note that this is consistent with T doing exactly the opposite in other 
subpopulations. All that we can be sure of from a positive difference is just that T is 
causally positive in some subpopulation. 
 
It is easy to provide sufficient conditions. T causes O in any new population θ in 
which both 
i) The same causal laws for O hold as in X (so that the same factors will be 
causes of O as in X);3 and 
ii) Some causally homogeneous subpopulation, φ, of X in which the 
probability of O is greater in the treatment than the non-treatment groups is a 
subpopulation of θ. 
Not only are these conditions sufficient for T to cause O in θ. They are also necessary 
to justify exporting study results to θ. After all if θ has different causal laws or 
different subpopulations than those causally positive in X it may be true that T causes 
O there but whether it does so in X is irrelevant. 
 
What if we back off though? Do not draw a causal conclusion; merely look at some 
probabilistic fact, for instance the effect size: the mean difference in O between the 
treatment and non-treatment groups in X. When will effect size be the same between 
X and θ? An answer requires assumptions about how the probability of O gets fixed. 
The most reasonable one we know is CF.4 Given CF, the following conditions are 
sufficient. The effect size is the same in θ as in X when  
i) X and θ are the same with respect to the causal laws for O; and 
ii) X and θ are the same with respect to the probability of all causally 
homogeneous subclasses.   
Otherwise it is an accident of the numbers.  
                                                 
3 If this condition doesn’t hold then it makes no difference if φ is a subpopulation of 
the new population since now φ is defined as a population in which some given set of 
factors all have the same values. But this is irrelevant if those factors are not the 
causal factors for O in the new population. 
4 So it seems causality must enter at some stage of reasoning. 
 So, very restrictive conditions must be met for effect size to travel from study to target 
populations. These conditions are restrictive not only in the sense that they may not 
hold widely, but also with respect to the epistemic demands they make. RCTs are now 
taken as a gold standard in causal inference throughout healthcare and social policy 
worlds because they are supposed to best control for bias from unknown confounders. 
So it is widely acknowledged that we generally don’t know all the important causes 
for a factor, let alone knowing the distribution of subpopulations homogeneous with 
respect to these in the study and the target populations as ii) requires.  
 
Nor is i) easier. Most causal and probabilistic relations relied on in healthcare and 
social practice are not fundamental: They do not just hold, they hold on account of 
some underlying structure that gives rise to them. When the structures are different, so 
too are the causal and probabilistic relations they create. For instance, stepping on the 
right-hand lever on the car floor – i.e., the throttle – causes the object the lever is 
attached to accelerate. Stepping on the lever attached to the end of a toaster produces 
something entirely different. In this example the underlying structures are mechanical. 
In cases of interest for health and social policy they will be a mix of institutional, 
psychological and physical. The basic lesson is the same. Different underlying 
structures yield different causal and probabilistic relations. The problem is we often 
do not understand these underlying structures nor how they work to give rise to the 
causal relations an intervention might use. So we don’t know when i) is satisfied. For 
some causal relations it may be good to assume, as one economist recently claimed, 
that people are much the same wheresoever they are; for others that assumption can 
be disastrous. So the demands for exporting effect size from study to target population 
are generally far too great.  
 
A weaker conclusion concerns the direction of the effect size: When will a positive 
effect size in X be sufficient for a positive effect size in θ? A number of separately 
sufficient conditions are immediately apparent. Effect-size direction will be the same  
  If T has same effect on every individual.5 
Or 
  If X and θ  
1. Have the same causal laws; and 
2. Unanimity: T acts in the same direction with respect to O in all causally 
homogeneous subpopulations.6 
Or 
  If θ has ‘the right’ subpopulations. 
 
Again, these are strong conditions that may often fail to obtain. Is there then no other 
kind of useful conclusion to be exported more widely? We believe there often is. To 
see what kind of conclusion that is we offer some simple distinctions among types of 
causal claims. 
 
 
4.  Three Kinds of Causal Claims 
 
                                                 
5 This is similar to a requirement made by Holland and Rubin [3]. 
6 Note for section 5 that this is sufficient but not necessary for the claim that T has a stable capacity to 
promote O. 
In order to understand the route from method-of-difference studies to effectiveness 
predictions it helps to distinguish three kinds of causal claims:  
 
1. It-works-somewhere claims: T causes O somewhere under some conditions 
(e.g. in study population X, administered by method M). 
2. Capacity claims: T has a (relatively) stable capacity to promote O. 
3. It-will-work-for-us claims: T would cause O in population θ administered as it 
would be administered given policy P (i.e., effectiveness claims). 
 
Given CF, method-of-difference studies can establish it-works-somewhere claims and 
medical and social sciences work hard to do so.7 But what makes these evidence for 
effectiveness claims: T would cause O in θ administered as it would be administered 
given policy P (T will work for us)? The standard answer is external validity. An 
alternative is capacities. 
 
 
5. Stable Capacities 
 
‘T has a stable capacity to promote O.’ What does this mean? Cartwright provides a 
detailed answer in a number of places [5, 6] and there is currently a great deal of work 
by other authors on the related (possibly identical) notion of a causal power [7-10].  
Rather than pursuing these details here some examples may suffice: Masses have a 
stable capacity to move other masses towards themselves; aspirins have a relatively 
stable capacity to relieve headaches. 
                                                 
7 See Meinert’s claim, in Steven Epstein’s book on diversity [4, p. 98]. 
 A factor with a (relatively) stable capacity to promote O always (or across a range of 
situations under consideration) makes the same fixed contribution towards O. But this 
can – indeed, generally does – differ from what outcomes occur when the factor is 
present. The mass of the earth always pulls objects towards itself even if a magnet or 
the table-top prevents them falling. Similarly aspirins generally have a positive effect 
on headaches even if my headache grows worse because of the stress of my job. At 
least the headache isn’t as bad as it would be without the aspirins. One might say that 
aspirins ‘try’ to relieve the headache or that the mass of the earth ‘tries’ to make the 
body fall, though of course no conscious effort is involved. 
 
In reasoning about effectiveness we often assume that factors have stable capacities. 
Consider for example the canonical explanation for the failure of the California class-
size-reduction programme. [11] A well-conducted RCT in Tennessee established that 
small class sizes there improved reading scores: The study supported an it-works-
somewhere claim. California reduced class sizes but reading scores did not improve. 
The usual explanation is not that the Tennessee study was flawed; nor that it was 
irrelevant due to different structural features in California; nor that it was an entirely 
local interactive effect from which no further lessons could be drawn.  
 
The canonical explanation points instead to the fact that California rolled out its 
programme over a short time. Suddenly class sizes were cut in half. Twice as many 
teachers were required and twice as much classroom space. Neither was available. So 
teaching quality and learning experiences went down along with class size. But not 
because smaller classes do not contribute positively to reading scores. Rather, so the 
explanation goes, their good effect was offset by the bad effect of poor teaching and 
poor educational surroundings. The California scores were a result of all the 
contributions, positive and negative, ‘added’ together, just as when a magnet and 
gravity act together on a pin that doesn’t fall.  
 
So, some factors have relatively stable capacities and we regularly rely on that in our 
reasoning. When causes do have stable capacities, what we learn about their 
contributions in method-of-difference studies8 can be exported to more situations than 
those where ‘external validity’ holds. External validity in all the forms we have 
discussed supposes that the same facts true in the study are true in the target, whether 
these be probabilistic facts or facts about what the factor causes (as opposed to what it 
contributes).  
 
There are however two major problems with capacities. First, Mill’s-method-of-
difference studies can’t establish them. A cause can make a difference in a specific 
situation yet there may be no stable contribution that can be relied on elsewhere. 
When there is a stable contribution we are entitled to what Mill called ‘the analytic 
method’. [12] That is, we can establish what each separate cause contributes, then rely 
on some ‘rule of combination’ – like vector addition with forces or simple scalar 
addition9  – to calculate what happens when a number of causes occur together.  But 
not all fields are open to the analytic method. Mill argued that it can be used in 
                                                 
8 What do we learn in method-of-difference studies about the contributions of causes, 
supposing there is a stable contribution there to begin with? What we see is an 
average of what the cause contributes across the causally homogeneous 
subpopulations in the study population. How we reason back from that to a 
representation of its contribution that can then be slotted into a rule of combination to 
predict what happen when the cause acts in consort with other causes depends heavily 
on what we otherwise know. 
9 For other rules of combination see [5] and [13]. 
mechanics and in political economy but not in chemistry. Chemistry, he thought, is 
more holistic: How a cause behaves depends on the other factors it interacts with and 
on its environment; what it does in one environment has little bearing on what it will 
do in another.  
 
So it is an empirical question where capacities are likely to occur, whether a given 
cause has a stable capacity and across what range it is stable. A method-of-difference 
study can reveal something about the contribution of a capacity but it cannot establish 
that there is a capacity there to begin with. How to establish that is a complicated 
matter – just look at what it has taken to establish which causes carry forces in 
mechanics (i.e., what causes make stable contributions to motions) and how these 
combine. Unfortunately the methodology for establishing claims that a factor has a 
capacity is not laid out with anything like the degree of completeness and rigor 
available for establishing other hypotheses, such as it-works-somewhere claims. 
 
Nevertheless a wealth of evidence of different kinds can clearly make specific 
capacity claims probable and when they are probable they are a powerful tool for 
predicting whether an intervention will work for us. What is observed in method-of-
difference studies will contribute to this evidence base but the history of mechanics 
should remind us that a lot more is necessary as well, even if we cannot lay out a 
recipe for what the required ingredients are. Nor should we be discouraged. There is a 
wealth of scientific successes where we have acquired just the kind of detailed 
knowledge necessary to bring together factors with different capacities to produce 
relatively predictable outcomes, from GPS systems to heart transplanting and 
prosthetic knees. 
  
6. Capacities and Contexts 
 
Establishing capacity claims then is difficult, far more difficult than establishing it-
works-somewhere claims. This is in part because claims that a factor has a capacity to 
make a given contribution neither make sense nor are testable in isolation.10 That’s 
because there are a number of substantial implications that must be met if a capacity 
is to be ascribed to a factor. In particular, ‘T has a stable capacity to promote O’ 
implies that there are facts of the matter about 
 
 Mode of operation: How T operates to promote O; 
 Necessary auxiliaries: What must be in place for T to operate to 
promote O; 
 Destroyers: What can destroy or overwhelm T’s operation; 
 What other capacities promote and retard O; 
 Rule of combination: what happens when many capacities are at work 
simultaneously? 
 
So capacity claims make sense only relative to a far larger body of knowledge. That 
is, ultimately we need what we would call a theory. This of course runs contrary to 
much of the founding hope for evidence-based health and social policy. After all, 
                                                 
10 Just consider precise claims about electromagnetic attraction and repulsion. This is never present on 
its own; gravitational attraction always acts as well. So these claims can only be properly tested by 
experiments on the motions of charged particles if we already know how to ‘subtract away’ the 
contributions of gravity. 
RCT  advocates like them because it seems no theory is required to do what they do – 
but recall, what they do is to establish ‘it-works-somewhere’ claims. 
 
Consider a case using everyday physics. We choose this because it is simple, well 
understood and does not involve subject-specific commitments in health and social 
care. Magnets have the capacity to lift objects. Claims about their attractive powers 
have passed far more than two good RCTs; they have centuries of study behind them. 
Imagine: you have access to a desk magnet and a large industrial magnet and you 
know the exact strengths of these with a high degree of certainty. Should you use one 
of them to lift an object in your driveway?  That depends on features of the object and 
its surroundings.  
 
First, magnets need helping factors to be effective. A desk magnet is useless for lifting 
a matchstick; it is only the combination of a magnet and a metal object that produces a 
magnetic force. To predict whether the magnet will work for you, you need to know 
what the necessary auxiliary factors are. 
 
Then the acceleration caused by the magnet is only one part of the story, often a small 
part. To know what happens when you use the magnet you need to know the other 
forces as well, especially gravity. The desk magnet may lift a pin but it is hopeless for 
your car, where you need the industrial magnet. You also need to watch for other 
forces you introduce while getting the magnet in place. Perhaps the industrial magnet 
would have lifted the car if you hadn’t thrown its heavy packing case into the boot. 
Finally, you need to know how all these factors combine to produce a result. Often in 
health care and social contexts simple additivity is assumed: Add a good thing and the 
results can only get better. But that doesn’t work in even this familiar physics case. 
We get so used to vector addition that we forget that it isn’t simple scalar addition. 
Add a magnetic acceleration of 42 ft/sec/sec to that of gravity’s 32 ft/sec/sec and you 
won’t necessarily get 74 ft/sec/sec.  
 
Whether and to what extent the magnet will be effective in the target situation 
depends on the causal structure there. It will be hard to make even roughly accurate 
predictions without investigating that situation and making a reasonable assessment of 
what the overall outcome will be when the relevant factors operate together.  
 
This can seem daunting. But consider: You know industrial magnets would pass any 
number of method-of-difference studies, of any degree of stringency. But that’s not 
anywhere near enough to know. None of us would rent an industrial magnet to 
remove a load of rubbish before examining the rubbish. Knowledge that magnets like 
this can lift is only a small part of what we consider when evaluating if the magnet 
will be effective in removing our rubbish. If this is so in everyday calculations and in 
applied science and engineering (like how to build a laser or an artificial limb), why 
expect predicting the effects of social and healthcare interventions to be substantially 
different – and substantially easier? 
 
Of course this kind of complicated causal reasoning is hard, even if we are prepared to 
be rough in our approximations and figure out ways to tolerate uncertainties. Happily 
sometimes there are shortcuts, what psychologist Gerd Gigerenzer calls ‘cheap 
heuristics’. [14] For instance, one powerful cause can swamp everything else so we 
needn’t model the rest. If you are shooting a bullet through someone’s heart you do 
not need to measure his cholesterol to calculate his longevity. Or, as with the magnet 
and the matchstick, the absence of some necessary auxiliary can show immediately 
that a policy will not be effective.  
 
Failing a nice heuristic for a case, we advise: Do your best with the resources and 
time available. But reason in a sensible way. Do not optimistically expect external 
validity without reason to think that sufficient conditions for it are satisfied. In the 
same vein do not suppose that causal factors have stable capacities without good 
reason. Embrace capacities where you have reason to believe they hold since they are 
a powerful tool. But then remember that more work is needed to make reasonable bets 
about what the outcome will be when a cause with a known capacity is introduced. 
And recognizing that knowledge is missing at every stage, be prepared to manage 
uncertainty.  
 
The next section gives a child welfare example to illustrate what options may be 
overlooked when we rely on a restricted set of evidence, mostly of an it-works-
somewhere kind, and ignore causal capacities, both the power they might provide for 
our reasoning and the problems they entail.  
 
 
7. Multisystemic Therapy (MST) 
 
A brief description of MST is: 
 
MST posits that youth antisocial behaviour is multi-determined and linked 
with characteristics of the individual youth and his or her family, peer group, 
school, and community contexts…. MST interventions typically aim to 
improve caregiver discipline practices, enhance family affective relations, 
decrease youth association with deviant peers, increase youth association with 
prosocial peers, improve youth school or vocational performance, engage 
youth in prosocial recreational outlets, and develop an indigenous support 
network of extended family, neighbors, and friends to help caregivers achieve 
and maintain such changes.  Specific treatment techniques used to facilitate 
gains are integrated from those therapies that have the most empirical support, 
including cognitive behavioral, behavioral, and the pragmatic family therapies. 
[15]  
 
MST has been widely adopted in North America and Europe and subject to many 
RCTs.  A systematic review for the Cochrane Collaboration identified thirteen studies 
as meeting the inclusion criteria for the review; it reported  that the results of these 
studies vary. [16]  Several studies found some positive outcomes for the young people 
treated but there is no consistency in which outcome variables show improvement; 
some show no improvement compared with standard intervention.  A large study in 
Ontario, Canada where MST was offered to juvenile delinquents, found no significant 
difference in reconviction rates at three year follow-up. Similarly an RCT in Sweden 
involving 4 sites and 156 youths who met the diagnostic criteria for conduct disorder 
reports: ‘There were no significant differences in treatment effects between the 2 
groups. The lack of treatment effect did not appear to be caused by site differences or 
variations in program maturity.’ [17] 
 Can policy makers use these mixed findings? The positive studies appear to show that 
MST ‘works somewhere’ but how can policy makers decide whether it will work for 
them? Current debates about MST show it is difficult to resolve these problems using 
the concept of external validity.   
 
 
Treatment Fidelity 
 
One explanation for the inconsistent findings is that workers were not implementing 
the intervention correctly. The premise ‘T causes O’ is not falsified since these were 
not instances of T. This is offered in explanation of the poor results from the Canadian 
study:  ‘[A]lthough the quality and quantity of adherence data are largely unknown, 
the site with apparently the worst adherence had the worst outcomes.’ [18, p. 454]  
 
The MST group, however, emphasise the importance of treatment fidelity and offer a 
package of services to secure it. [19] The Swedish study made measuring treatment 
fidelity one of the key aims in order to test whether it explained outcomes. [20] But 
their fidelity scores did not differ significantly among the six MST teams.  On two 
outcome measures, higher fidelity scores were significantly correlated with higher 
outcome scores but there was no significant difference on the remaining factors.  
Therapists with high fidelity scores were compared with those with low scores.  The 
results were mixed. On eight measures higher scores indicated more favourable 
outcomes, while for ten measures the effect sizes indicated a negative outcome for the 
group with the highest fidelity measure. [17, p. 557]  
 A related claim is that as the programme becomes embedded workers become more 
expert at applying the intervention: Programme maturity improves outcomes. Again, 
the evidence on this is mixed. [18, p. 453 and 17, p. 557]  
 
 
Weighing the Evidence 
 
Since treatment fidelity and programme maturity fail to provide convincing 
explanations of the inconsistent results, the field seems confused about how to rate 
MST.  Using the advice guides for grading policy predictions, top grades could be 
awarded to it because more than two good Mill’s-method-of-difference studies 
support it. Unfortunately, more than two good studies don’t. In the health and welfare 
field, most of the organisations that rate interventions include MST as having 
demonstrated evidence of effectiveness.  Indeed the MST website provides a list of 
prestigious organisations that offer this endorsement. [21] But for the Canadians and 
Swedes who spent millions of pounds on the MST license and on evaluating their 
services this endorsement has been misleading.  How should others proceed given this 
mixed message? 
 
Section 3 stated that the effect size is the same in  target population θ as in study 
population X when  
i) X and θ are the same with respect to the causal laws for O; and 
ii) X and θ are the same with respect to the probability of all causally 
homogeneous subclasses.   
 The inconsistent findings indicate that these two premises are not true for Canadian 
and Swedish populations.  Either there are causal factors in Canadian and Swedish 
populations that are significantly different from those in the positive studies in some 
US states or their distributions are different enough to account for the differences in 
effect size. The trouble is, how do we work out what these are? Traditional advice on 
RCTs seeks to control for unknown confounders through randomization but this 
clearly is inadequate in this case since all studies were randomized.  In the positive 
RCTs the variation in the factors showing significant improvements suggests that, 
even in this group, there are different causal factors in operation.  How are we to find 
out which factors matter? 
 
 
Stable Capacities 
 
Instead of some overall judgment that it will, or will not, work in new sites, can we 
identify stable capacities in MST instead? Capacities that because of site structure 
differences do not produce consistently positive results?  There are some ready 
candidates for such a label.  MST was developed using empirical research on key risk 
and protective factors for youth antisocial behaviour and incorporates empirically-
based treatments insofar as they exist, e.g. cognitive behavioural approaches, 
behavioural parent training.  It has nine core treatment principles all of which have 
empirical support or are generally viewed as good practice, e.g. being positive and 
strength focused, present-focused, action-oriented and well-defined. The focus of 
theoretical exploration could thus be on what factors destroy or overwhelm T’s 
operation, what other capacities promote or retard O, and what happens when many 
factors are at work simultaneously.   
 
However, considerable work needs to be done both in theoretical development and 
testing to identify the contribution of other factors.  Efforts to explain the discrepant 
results to date do not generally consider capacities but the Swedish results produce 
speculations that fit better with the concept of capacities than with ‘it-works’ claims.  
 
One hypothesis, for example, is that MST had positive results compared to Treatment 
as usual (TAU). TAU varies between states and countries so negative results may 
arise because TAU in those sites is so similar to MST, i.e. MST does work but so does 
TAU so policy makers need to consider their relative cost-effectiveness. [17] This is 
plausible given MST’s roots in empirically supported assumptions.  However, to test 
this hypothesis work needs to be done analysing TAU to discover how and how much 
it resembles MST. Such research might strengthen claims to have identified stable 
capacities and help us understand how they operate in situ. 
 
One explanation of the Swedish findings points to the differences in the social 
context.  In the U.S. juvenile offenders are treated by the justice system; in Sweden 
they fall almost always within the child welfare system and this, Sundell and 
colleagues suggest, promotes rehabilitation whatever the method. [17] However, this 
also holds true for Norway and MST achieved positive outcomes there so any link is 
not straightforward.  Sundell and colleagues also identify poorer and higher crime and 
substance abuse neighbourhoods in the U.S. as more difficult contexts where the 
greater power of MST is required to reduce offending while the less powerful TAU is 
sufficient in Sweden. These speculations are examples of efforts to identify necessary 
auxiliaries (what must be in place for T to operate to promote O) and other factors that 
promote or retard O. However, the debate is under-developed and there is little show 
of sustained attempts to test these speculations more rigorously. 
 
On the whole, the debate on how to interpret the results still centres around trying to 
determine whether MST does or does not work, sometimes deteriorating to personal 
attacks on one’s opponents which suggests the disputants are unsure how to progress 
the debate when the usual pathway of labelling an intervention as effective is blocked.   
 
 
8. Conclusion 
 
Evidence-based policy and evidence-based practice are highly valued in health and 
social care.  The dominant view at present of what evidence is reliable gives greatest 
weight to evidence from RCTs.  This, it has been argued, is insufficient to meet the 
needs of policy or practice decision makers.  A properly conducted RCT provides 
evidence that the intervention works somewhere (i.e. in the trial).  The decision 
maker, however, needs to estimate ‘will it work for us?’  In health and social care the 
underlying social and physical structures in which an intervention is devised cannot 
automatically be assumed to be comparable to target localities in causally relevant 
aspects (assuming we knew what these were).  Differences in institutional, 
psychological and physical factors yield different causal and probabilistic relations. 
Sweden and the U.S., for example, have radically different ways of conceptualising 
and responding to antisocial behaviour among young people.  The examples cited of 
California class-size reduction and MST illustrate that we need much more 
information to jump from ‘it works somewhere’ to ‘it will work for us’.   
 
The concept of external validity is inadequate for the task since it assumes that the 
same facts observed in the study will occur in the target and this is rarely plausible in 
health and social care contexts.  Stable capacities are an alternative.  A factor T that 
has a relatively stable tendency to promote O makes a fixed contribution towards O in 
varied situations but this can, indeed generally does, differ from what occurs when the 
factor is present.  Other factors may neutralise or enhance the positive effects of T so 
results can vary. While this looks a potentially more constructive way to evaluate 
adopting interventions with some RCT support, it is not simple. The methodology for 
establishing tendency claims is not laid out with anything like the completeness or 
rigor we have for establishing it-works-somewhere claims, using, for instance, 
method-of-difference studies. Claims that a factor T has a stable tendency cannot be 
tested in isolation. Research has to identify how T operates to promote O; what must 
be in place for T to operate to promote O; what can destroy or overwhelm T’s 
operation; what other factors promote or retard O; and what happens when many 
factors are at work simultaneously. Ultimately, we need theory to judge which factors 
have stable capacities and to hypothesise when they are worth implementing. 
 
The MST dispute illustrates the limitations of standard approaches to weighing 
evidence. MST has been subjected to several rigorous RCTs but these produced 
varied results. For the policy maker considering whether to implement it, the current 
situation is bewildering. There certainly is evidence that ‘it works somewhere’ but 
should the policy maker risk adopting it?  Experiences in Canada and Sweden tell 
against this, whereas that of Norway favours it.  The dispute cannot be settled by a 
power struggle or by conducting more RCTs to see if the balance of success to failure 
shifts. Decision makers needs specific information to help judge whether it will be 
successful in their particular social context. This requires much more theoretical 
understanding of how MST operates and what factors in the environment help or 
hinder it. More RCTs and other methods able to establish it-works-somewhere claims 
alone will not settle these questions. A different kind of research, testing hypotheses 
about the role of other factors, is required to build a detailed picture of the 
circumstances under which MST is a valuable intervention. 
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